64
Participants
Start Date
July 31, 2009
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
CNTO 3649 10 mcg/kg
A single dose of 10 mcg/kg of CNTO 3649 will be administered as subcutaneous injection to healthy adult Japanese men.
CNT0 3649 30 mcg/kg
A single dose of 30 mcg/kg of CNTO 3649 will be administered as subcutaneous injection to healthy adult Japanese men and multiple doses of 30 mcg/kg of CNTO 3649 will be administered to participants with type 2 diabetes mellitus as subcutaneous injections once weekly for 4 weeks.
CNTO 3649 100 mcg/kg
A single dose of 100 mcg/kg of CNTO 3649 will be administered as subcutaneous injection to healthy adult Japanese men and multiple doses of 100 mcg/kg of CNTO 3649 will be administered to participants with type 2 diabetes mellitus as subcutaneous injections once weekly for 4 weeks.
CNTO 3649 300 mcg/kg
A single dose of 300 mcg/kg of CNTO 3649 will be administered as subcutaneous injection to healthy adult Japanese men.
Placebo
Matching Placebo to CNTO 3649 will be administered to both healthy volunteers and participants with type 2 diabetes mellitus.
Fukukoka
Lead Sponsor
Janssen Pharmaceutical K.K.
INDUSTRY